Depending on the context, nanotechnologies developed as nanomedicines (nanosized
therapeutics and imaging agents) are presented as either a remarkable technological …

Synthetic methods in polymer chemistry have evolved tremendously during the last decade.
Nowadays more and more attention is devoted to the application of those tools in the …

More than 40 nanomedicines are already in routine clinical use with a growing number
following in preclinical and clinical development. The therapeutic objectives are often …

Since the early 1990s polymer–protein conjugates (included PEGylated enzymes and
cytokines), polymeric drugs and polymeric sequestrants have been entering the market as …

In the field of nanomedicine, ample attention has been paid to the development of
nanocarriers for the intracellular delivery of therapeutic cargo, such as nucleic acids for gene …

Multidisciplinary research efforts in the field of drug delivery have led to the development of
a variety of drug delivery systems (DDS) designed for site-specific delivery of diagnostic and …

Polypeptides are envisaged to achieve a major impact on a number of different relevant
areas such as biomedicine and biotechnology. Acquired knowledge and the increasing …

Targeting angiogenesis-related pathologies, which include tumorigenesis and metastatic
processes, has become an attractive strategy for the development of efficient guided …

The liver is constantly exposed to dietary antigens, viruses, and bacterial products with
inflammatory potential. For decades cellular uptake of virus has been studied in connection …

In order to better understand nanoparticle uptake and elimination mechanisms, we designed
a controlled set of small, highly fluorescent quantum dots (QDs) with nearly identical …